Cambridge Investment Research Advisors, Inc. Simulations Plus, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$40.03 - $51.51 $2.25 Million - $2.89 Million	56,153 New	56,153 $2.34 Million
Q3 2022 Oct 17, 2022	SELL	$47.75 - $66.88 $5,013 - $7,022	-105 Reduced 2.48%	4,129 $200,000
Q2 2022 Jul 13, 2022	SELL	$40.55 - $51.76 $21,045 - $26,863	-519 Reduced 10.92%	4,234 $208,000
Q1 2022 May 12, 2022	SELL	$36.56 - $50.98 $8,006 - $11,164	-219 Reduced 4.4%	4,753 $242,000
Q4 2021 Feb 03, 2022	BUY	$37.1 - $57.45 $184,461 - $285,641	4,972 New	4,972 $235,000

Others Institutions Holding SLP

# of Institutions

175

Shares Held

15.1M

Call Options Held

5.4K

Put Options Held

1.4K

View Full List

About Simulations Plus, Inc.

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $582M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

More about SLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account